Madhi SA - Search Results

1

Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals.

Nunes MC, Madhi SA. Nunes MC, et al. Among authors: madhi sa. Hum Vaccin Immunother. 2012 Feb;8(2):161-73. doi: 10.4161/hv.18432. Epub 2012 Feb 1. Hum Vaccin Immunother. 2012. PMID: 22426374 Free PMC article. Review.

2

Pneumococcal conjugate vaccine--prospects for intervention in children.

Madhi SA, Klugman KP. Madhi SA, et al. Semin Respir Infect. 1999 Sep;14(3):285-94. Semin Respir Infect. 1999. PMID: 10501316 Review. No abstract available.

3

The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia.

Ruffini DD, Madhi SA. Ruffini DD, et al. Among authors: madhi sa. AIDS. 2002 Jan 4;16(1):105-12. doi: 10.1097/00002030-200201040-00013. AIDS. 2002. PMID: 11741168

4

Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection.

Madhi SA, Petersen K, Khoosal M, Huebner RE, Mbelle N, Mothupi R, Saloojee H, Crewe-Brown H, Klugman KP. Madhi SA, et al. Pediatr Infect Dis J. 2002 Apr;21(4):315-21. doi: 10.1097/00006454-200204000-00011. Pediatr Infect Dis J. 2002. PMID: 12075763

5

Defining the potential impact of conjugate bacterial polysaccharide-protein vaccines in reducing the burden of pneumonia in human immunodeficiency virus type 1-infected and -uninfected children.

Madhi SA, Cumin E, Klugman KP. Madhi SA, et al. Pediatr Infect Dis J. 2002 May;21(5):393-9. doi: 10.1097/00006454-200205000-00009. Pediatr Infect Dis J. 2002. PMID: 12150175

6

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.

Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N; Vaccine Trialists Group. Klugman KP, et al. Among authors: madhi sa. N Engl J Med. 2003 Oct 2;349(14):1341-8. doi: 10.1056/NEJMoa035060. N Engl J Med. 2003. PMID: 14523142 Free article. Clinical Trial.

7

A role for Streptococcus pneumoniae in virus-associated pneumonia.

Madhi SA, Klugman KP; Vaccine Trialist Group. Madhi SA, et al. Nat Med. 2004 Aug;10(8):811-3. doi: 10.1038/nm1077. Epub 2004 Jul 11. Nat Med. 2004. PMID: 15247911 Free PMC article. Clinical Trial.

8

Use of procalcitonin and C-reactive protein to evaluate vaccine efficacy against pneumonia.

Madhi SA, Heera JR, Kuwanda L, Klugman KP. Madhi SA, et al. PLoS Med. 2005 Feb;2(2):e38. doi: 10.1371/journal.pmed.0020038. Epub 2005 Feb 22. PLoS Med. 2005. PMID: 15736995 Free PMC article. Clinical Trial.

9

The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.

Madhi SA, Kuwanda L, Cutland C, Klugman KP. Madhi SA, et al. Clin Infect Dis. 2005 May 15;40(10):1511-8. doi: 10.1086/429828. Epub 2005 Apr 7. Clin Infect Dis. 2005. PMID: 15844075 Clinical Trial.

10

Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children.

Madhi SA, Kuwanda L, Cutland C, Holm A, Käyhty H, Klugman KP. Madhi SA, et al. Pediatr Infect Dis J. 2005 May;24(5):410-6. doi: 10.1097/01.inf.0000160942.84169.14. Pediatr Infect Dis J. 2005. PMID: 15876939 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

706 results

Search Page

Filters